MedPath

Effect of intraoperative warmed, humidified carbon dioxide insufflation in open laparotomy colorectal surgery patients undergoing Cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS HIPEC): a randomized controlled trial (Second WHCO2 trial)

Not Applicable
Recruiting
Conditions
Colorectal cancer
Peritoneal Metastases
Cancer - Bowel - Back passage (rectum) or large bowel (colon)
Registration Number
ACTRN12623000950662
Lead Sponsor
Sydney Local Health District
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Colorectal adenocarcinoma peritoneal metastases confirmed on biopsy at time of diagnostic laparoscopy, Peritoneal cancer index score (diagnostic laparoscopic) <15, Intention to achieve Completeness of cytoreduction score (CCR) of 0. Willingness to provide informed consent and willingness to participate and comply with the study requirements.

Exclusion Criteria

Extraperitoneal metastasis (current),
Liver metastases,
Non-colorectal adenocarcinoma,
Inability to achieve CCR0,
Inoperable peritoneal carcinomatosis ,
PCI on diagnostic laparoscopy of more than 15,
During laparotomy for CRS/HIPEC, two surgeons agree and decide tumour spread is so advanced that proceeding with operation is futile or too dangerous (however will be analysed as intention to treat),
ECOG score >2,
Charlson Comorbidity index more than 8,
PCI (diagnostic laparoscopic)>16

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath